<VariationArchive VariationID="645882" VariationName="NC_000023.10:g.(?_149831886)_(149840088_?)del" VariationType="Deletion" Accession="VCV000645882" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2019-08-14" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="653281" VariationID="645882">
      <GeneList>
        <Gene Symbol="MTM1" FullName="myotubularin 1" GeneID="4534" HGNC_ID="HGNC:7448" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="150562653" stop="150673143" display_start="150562653" display_stop="150673143" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="149737046" stop="149841615" display_start="149737046" display_stop="149841615" Strand="+" />
          </Location>
          <OMIM>300415</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MTM1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MTM1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000023.10:g.(?_149831886)_(149840088_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" innerStart="149831886" innerStop="149840088" display_start="149831886" display_stop="149840088" variantLength="8203" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.(?_149831886)_(149840088_?)del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.(?_149831886)_(149840088_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000023.10:g.(?_149831886)_(149840088_?)del AND Severe X-linked myotubular myopathy" Accession="RCV000800047" Version="3">
        <ClassifiedConditionList TraitSetID="1981">
          <ClassifiedCondition DB="MedGen" ID="C0410203">Severe X-linked myotubular myopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-08-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-08-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-08-14" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10790201</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12522554</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20434914</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1981" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5607" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MYOTUBULAR MYOPATHY 1</ElementValue>
                <XRef Type="MIM" ID="310400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked centronuclear myopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myotubular myopathy, X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Severe X-linked myotubular myopathy</ElementValue>
                <XRef ID="Severe+x-linked+myotubular+myopathy/9289" DB="Genetic Alliance" />
                <XRef ID="46804001" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CNMX</ElementValue>
                <XRef Type="MIM" ID="310400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MTM1</ElementValue>
                <XRef Type="MIM" ID="310400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MTMX</ElementValue>
                <XRef Type="MIM" ID="310400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XLMTM</ElementValue>
                <XRef Type="MIM" ID="310400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="11925" />
                <XRef ID="11925" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">X-linked myotubular myopathy (X-MTM), also known as myotubular myopathy (MTM), is characterized by muscle weakness that ranges from severe to mild. Approximately 80% of affected males present with severe (classic) X-MTM characterized by polyhydramnios, decreased fetal movement, and neonatal weakness, hypotonia, and respiratory failure. Motor milestones are significantly delayed and most individuals fail to achieve independent ambulation. Weakness is profound and often involves facial and extraocular muscles. Respiratory failure is nearly uniform, with most individuals requiring 24-hour ventilatory assistance. It is estimated that at least 25% of boys with severe X-MTM die in the first year of life, and those who survive rarely live into adulthood. Males with mild or moderate X-MTM (~20%) achieve motor milestones more quickly than males with the severe form; many ambulate independently, and may live into adulthood. Most require gastrostomy tubes and/or ventilator support. In all subtypes of X-MTM, the muscle disease is not obviously progressive. Female carriers of X-MTM are generally asymptomatic, although manifesting heterozygotes are increasingly being identified. In affected females, symptoms range from severe, generalized weakness presenting in childhood, with infantile onset similar to affected male patients, to mild (often asymmetric) weakness manifesting in adulthood. Affected adult females may experience progressive respiratory decline and ultimately require ventilatory support.</Attribute>
                <XRef ID="NBK1432" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301605</ID>
                <ID Source="BookShelf">NBK1432</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2012">
                <ID Source="PubMed">22617344</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Frase, 2016">
                <URL>http://online.liebertpub.com/doi/10.1089/hum.2016.29024.arf</URL>
              </Citation>
              <XRef ID="596" DB="Orphanet" />
              <XRef ID="C0410203" DB="MedGen" />
              <XRef ID="MONDO:0010683" DB="MONDO" />
              <XRef Type="MIM" ID="310400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1833647" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="NM_000252.2_X_Deletion (exons 14-15)|MedGen:C0410203" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000939744" DateUpdated="2024-06-09" DateCreated="2019-08-14" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-08-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10790201</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12522554</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20434914</ID>
          </Citation>
          <Comment>Other truncations (p.Leu498*, p.Glu517*, p.Arg520*, p.Tyr523*, p.Trp537*) that lie downstream of this variant have been reported in individuals affected with X-linked myotubular myopathy (PMID: 10790201, 12522554, 20434914). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with MTM1-related disease. This variant is a gross deletion of the genomic region encompassing exons 14-15 of the MTM1 gene. The 5' boundary is likely confined to intron 13. The 3' end of this event is unknown as it extends through the termination codon beyond the assayed region for this gene and may encompass additional genes. While this deletion is not anticipated to result in nonsense mediated decay, it is expected to create a truncated protein product or disrupt mRNA translation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MTM1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_149831886)_(149840088_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0410203" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12974844</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1833647" TraitType="Disease" MappingType="XRef" MappingValue="C0410203" MappingRef="MedGen">
        <MedGen CUI="C0410203" Name="Severe X-linked myotubular myopathy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

